- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/34 - Atomes d'oxygène
Détention brevets de la classe C07D 277/34
Brevets de cette classe: 233
Historique des publications depuis 10 ans
|
18
|
14
|
19
|
11
|
23
|
5
|
13
|
12
|
8
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cirius Therapeutics, Inc. | 26 |
8 |
| The Board of Regents of the University of Texas System | 2202 |
7 |
| Cv6 Therapeutics (NI) Limited | 32 |
7 |
| Poxel SA | 21 |
6 |
| Metabolic Solutions Development Company, LLC | 27 |
5 |
| Shionogi & Co., Ltd. | 867 |
5 |
| Immunesensor Therapeutics, Inc. | 35 |
5 |
| Bayer Pharma AG | 1061 |
4 |
| The Regents of the University of California | 19839 |
3 |
| Janssen Pharmaceutica N.V. | 3413 |
3 |
| Syngenta Participations AG | 1912 |
3 |
| Syngenta Crop Protection AG | 6036 |
3 |
| Abbott Laboratories | 2409 |
3 |
| Sumitomo Chemical Company, Limited | 9018 |
3 |
| University of Southern California | 2109 |
3 |
| CalciMedica, Inc. | 81 |
3 |
| Industry-Academic Cooperation Foundation, Chosun University | 298 |
3 |
| Pusan National University Industry-University Cooperation Foundation | 658 |
3 |
| Merck Sharp & Dohme LLC | 3743 |
3 |
| LG Chem, Ltd. | 17564 |
2 |
| Autres propriétaires | 151 |